348 related articles for article (PubMed ID: 17965335)
1. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
Hu H; Shikama Y; Matsuoka I; Kimura J
J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
[TBL] [Abstract][Full Text] [Related]
2. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor promotes functional maturation of O-2 generating system during differentiation of HL-60 cells to neutrophil-like cells.
Yamaguchi T; Yamaguchi T; Hayakawa T
Arch Biochem Biophys; 1998 May; 353(1):93-100. PubMed ID: 9578604
[TBL] [Abstract][Full Text] [Related]
4. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
[TBL] [Abstract][Full Text] [Related]
5. Analysis of granulocyte-macrophage colony-stimulating factor action in differentiating myeloid leukemia cells: treatment with DMSO may reveal a common pathway for growth factor gene regulation.
Taetle R; Oval J; Smedsrud M; Davis C; Gansbacher B
Exp Hematol; 1991 Mar; 19(3):213-20. PubMed ID: 1995312
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17).
Kishi K; Toba K; Azegami T; Tsukada N; Uesugi Y; Masuko M; Niwano H; Hashimoto S; Sakaue M; Furukawa T; Koike T; Takahashi H; Maekawa T; Abe T; Aizawa Y
Exp Hematol; 1998 Feb; 26(2):135-42. PubMed ID: 9472803
[TBL] [Abstract][Full Text] [Related]
8. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
[TBL] [Abstract][Full Text] [Related]
9. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils.
Dragon S; Saffar AS; Shan L; Gounni AS
Mol Immunol; 2008 Jan; 45(1):160-8. PubMed ID: 17555818
[TBL] [Abstract][Full Text] [Related]
10. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
11. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro.
Wolach B; van der Laan LJ; Maianski NA; Tool AT; van Bruggen R; Roos D; Kuijpers TW
Exp Hematol; 2007 Apr; 35(4):541-50. PubMed ID: 17379064
[TBL] [Abstract][Full Text] [Related]
12. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
Caldas H; Honsey LE; Altura RA
Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells.
Giannì M; Norio P; Terao M; Falanga A; Marchetti M; Rambaldi A; Garattini E
Eur Cytokine Netw; 1995; 6(3):157-65. PubMed ID: 8589272
[TBL] [Abstract][Full Text] [Related]
14. Survivin: a bifunctional inhibitor of apoptosis protein.
Johnson ME; Howerth EW
Vet Pathol; 2004 Nov; 41(6):599-607. PubMed ID: 15557069
[TBL] [Abstract][Full Text] [Related]
15. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
[TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis.
Tortorella C; Piazzolla G; Spaccavento F; Antonaci S
Mediators Inflamm; 1998; 7(6):391-6. PubMed ID: 9927231
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
18. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony-stimulating factor enhances retinoic acid-induced gene expression.
Shimizu T; Esaki L; Mizuno H; Takeda K
J Leukoc Biol; 2006 Oct; 80(4):889-96. PubMed ID: 16885501
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
Moriai R; Asanuma K; Kobayashi D; Yajima T; Yagihashi A; Yamada M; Watanabe N
Anticancer Res; 2001; 21(1B):595-600. PubMed ID: 11299811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
